Research programme: cancer and infectious disease therapeutics - Caliber Biotherapeutics

Drug Profile

Research programme: cancer and infectious disease therapeutics - Caliber Biotherapeutics

Alternative Names: Infectious disease vaccines - Caliber Biotherapeutics; Pandemic influenza vaccine - Caliber Biotherapeutics/DARPA; Plant-made pharmaceuticals (PMP) based biobetter mAb candidates - Caliber Biotherapeutics; Rituxan biobetter candidate for cancer - Caliber Biotherapeutics; Rituximab biobetter candidates - Caliber Biotherapeutics

Latest Information Update: 13 Jun 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Caliber Biotherapeutics
  • Developer Caliber Biotherapeutics; Defense Advanced Research Projects Agency
  • Class Biobetters; Influenza A vaccines; Monoclonal antibodies; Vaccines
  • Mechanism of Action B cell inhibitors; CD20 antigen inhibitors; Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Research Cancer; Influenza A virus infections

Most Recent Events

  • 13 Jun 2013 Early research for Cancer is ongoing in USA
  • 13 Jun 2013 Early research in Influenza A virus infections (prevention) in USA (Parenteral)
  • 27 Apr 2011 Cancer and infectious disease therapeutics (Caliber Biotherapeutics) are available for licensing as of 25 Apr 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top